-
Cancer Imaging System Market Introduction:
Cancer is a disorder in which many of the body's cells develop uncontrollably and spread to various parts of the body. Cancerous tumors spread by tissue, and may proliferate to distant places within the human body, forming new tumors in the process. The excessive consumption of alcohol, tobacco, the adoption of poor lifestyle choices, the lack of physical fitness, and other related illnesses such as diabetes, etc., may also result in the development of diverse cancer types. Most cancer mortality rates may reduce, if detected early. According to the World Health Organization (WHO), cancer is the second primary purpose for the loss of life on a global-scale, with the cancer death rate being about 10 million in 2020. Globally, approximately 1 out of 6 deaths occur due to cancer. According to the WHO, there were over 2.3 million women who were diagnosed with breast cancer, and claimed the lives of 685,000 globally in 2020.
According to the World Health Organization, globally, an estimated 19.3 million new cancer cases and almost 10 million cancer deaths were indexed in 2020. Woman's breast cancer exceeds lung cancer rates with an estimated 3 million new cases (11.7%), followed by lung cancer (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers.
A Cancer Imaging System (CIS) plays a massive role in detecting most cancers as it provides an in-depth analysis of the exact location and volume of a given ailment. It additionally presents targeted information about structural or other cancer-related modifications. The CIS enables the detection of a tumor. It also allows for the evaluation of therapeutic & non-therapeutic modifications, various complications of a given treatment, and to facilitate the early detection of potential recurrence. Thus, the early screening and correct diagnosis are of paramount importance. A cancer imaging system department focuses on molecular imaging, purposeful genomics, and the high throughput of technologies focusing on mechanism-based fundamental, preclinical and medical-translation research of cancer.
Six primary cancer imaging diagnosis systems to treat human cancer are:
- X-ray (undeniable film and Computed Tomography [CT])
- Ultrasound (US)
- Magnetic Resonance Imaging (MRI)
- Single-Photon Emission Computed Tomography (SPECT)
- Positron Emission Tomography (PET)
- Optical imaging
Global Cancer Imaging System Market Revenue Outlook:
The global cancer imaging system industry is expected to index a market valuation of USD 12.24 Bn by 2026, and is further projected to register а САGR of 5.3% by 2031. The global cancer imaging system market is segmented on the basis of product type, diseases indications, end-users, and regions. In terms of product type, the Computerized Tomography (CT) sub-segment is to grow exponentially in terms of revenue. The markets in North America are slated to account for a higher market revenue share, followed by those in Europe. This can be attributed to the large presence of key market players in this respective region, advanced research infrastructure, as well as the availability of resources and advanced technologies. Markets in the Asia Pacific region are expected to emerge as the fastest-growing segment of this global industry, in terms of CAGR, owing to improved manufacturing activities, a growing awareness of cancer disease prevention and treatment, as well as increased R&D funding, particularly in emerging economies such as China and India.
Cancer Imaging System Market Dynamics:
- Increasing cases of numerous varieties of cancer throughout the globe, a spike in public awareness levels concerning the importance of early cancer analysis, and various technological advancements in diagnostic structures are some primary factors that continue to fuel worldwide marketplace sales.
- Cancer imaging systems are gaining popularity and are becoming an essential form of equipment necessary for early cancers detection and diagnostics, thereby reducing the mortality rate in the process.
- The demand for CIS has increased on a large-scale due to early disease diagnosis, a rapidly growing global population, the subsequent increase in chronic diseases, technological advancements in the diagnostic imaging industry, as well as increasing investments, funds, and grants by public-private organizations towards this given global market.
COVID-19 Impact Analysis on Cancer Imaging System Market:
The COVID-19 epidemic has resulted in the enforcement of respective lockdowns, either complete or partial, and this in turn immensely affected trade activities across several countries. This crisis has drastically impacted small-scale hospitals and imaging centers owing to their smaller-sized budgets. This pandemic even impacted respective supply chains deemed necessary for various cancer imaging system manufacturing companies. The gap between market demand and supply drastically increased, making it difficult for manufacturers and distributors to manage their operations effectively. A growing number of organizations were forced to either temporarily halt dat-to-day activities or had to downsize their existing workforce to further compensate.
Cancer Imaging System Market Drivers:
- According to statistical data, in 2020, there have been almost 10 million cancer deaths globally. In 2030, this figure is expected to reach 14 million, and is expected to increase to 16.3 million by 2040. The most familiar type of cancer in 2020 was breast cancer. However, lung cancer has been found to be the deadliest form of cancer.
- Growth in technology and a surge in the demand for lab automation are principal elements anticipated to propel the worldwide cancer imaging system marketplace forward over the forecast period. The number of private diagnostic facilities are also growing in number across the globe. There may be an increase in the requirement for various diagnostic imaging methods, and an increased burden on hospitals as a direct result of the limited number of imaging methodologies that are at their disposal.
- A lack in adequate skilled laborers or technicians necessary to operate these lab centers has not dampened the ever-increasing demand for these types of infrastructure across the world, particularly over the last few years. It is a reasonably effective solution to address less skilled personnel and aids in lowering human intervention in various laboratory techniques.
Cancer Imaging System Market Restraints:
- Companies face several types of risks—both internal and external. One risk in particular is product recall, which typically occurs after a product or service has reached its consumers. No enterprise ever desires to deal with a product recall case. A product recall can change a business enterprise's financial profile, its overall performance inside the market, and may have a negative impact on the company’s brand image.
- According to the Food and Drug Administration (FDA) data, the intended use of SIEMENS branded linear accelerator systems delivers x-ray photon and electron radiation for cancer therapy. The company soon became aware of a potential issue resulting in a service engineer receiving electrical shocks. In this case, a manufacture must make amends and take appropriate action to avoid further penalties. A product recall is the process of replacing and retrieving defective goods.
Report Scope:
- Forecast Period: 2022-2028
- Actual Year: 2021
- Historical Data Available for: 2015-2020
The Market for Global Cancer Imaging System Market is segmented based on Product Type, Disease Indications, End-Users, and Region
By Product Type:
- Computerized Tomography(CT)
- Mammography
- Magnetic resonance imaging (MRI)
- Ultrasound
- Positron Emission Tomography (PET)
- Other Products
Disease Indication:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma Cancer
- Prostate Cancer
- Kidney Cancer
End User:
- Hospitals and Clinics
- Diagnostic Centers
- Other End Users
Competitive Landscape:
The leading manufacturers operating in the cancer imaging system are stated below
- GE Healthcare
- Hitachi Medical
- Becton, Dickinson
- Konica Minolta
- Neusoft Medical
- Esaote
- Dilon Diagnostics
- Fujifilm Holdings Corporation
- Toshiba Medical Corporation
- Thermo Fisher Scientific Inc.
- Cr Bard Inc.
- Agilent Technologies
- Abbott
- Illumina Inc.
- Roche
- Philips Healthcare
- Other Key Players
Key Regions Covered:
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Israel
- Rest of MEA
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- GE Healthcare
- Hitachi Medical
- Becton, Dickinson
- Konica Minolta
- Neusoft Medical
- Esaote
- Dilon Diagnostics
- Fujifilm Holdings Corporation
- Toshiba Medical Corporation
- Thermo Fisher Scientific Inc.
- Cr Bard Inc.
- Agilent Technologies
- Abbott
- Illumina Inc.
- Roche
- Philips Healthcare
- Other Key Players
-
- Chapter 1 Global Cancer Imaging System Market Outlook
- 1.1 Introduction
- 1.2 Segmentation of Cancer Imaging System Market Based On Product Type, Disease Indication, End-User and Region
- 1.3 Market Drivers
- 1.4 Market Restraints
- 1.5 Market Opportunities
- 1.6 Market Trends
- 1.7 Macro-economic Factors
- 1.8 Regulatory Framework
- 1.9 Global Cancer Imaging System Market Pricing Analysis by Region, 2021
- 1.10 Opportunity Map Analysis
- 1.10.1 Optimistic Scenario
- 1.10.2 Likely Scenario
- 1.10.3 Conservative Scenario
- 1.11 Opportunity Orbits
- 1.12 Market Investment Feasibility Index
- 1.13 PEST Analysis
- 1.14 PORTER’S Five Force Analysis
- 1.15 Drivers & Restraints Impact Analysis
- 1.16 Marketing Strategy
- 1.17 Product Life Cycle Analysis
- 1.18 Value Chain Analysis
- 1.19 Cost Structure Analysis
- 1.20 Regional Market Share and BPS Analysis in Cancer Imaging System Market
- 1.21 COVID-19 Impact Analysis
- Chapter 2 Global Cancer Imaging System Market Overview
- 2.1 Global Market Value & Volume Comparison by Product Type (2015-2031)
- 2.1.1 Global Market Value & Volume Market Share by Product Type in 2021
- 2.1.2 Global Market Attractiveness Analysis by Product Type, 2015–2022
- 2.2 Global Market Value & Volume Comparison by Disease Indication (2015-2031)
- 2.2.1 Global Market Value & Volume Market Share by Disease Indication in 2021
- 2.2.2 Global Market Attractiveness Analysis by Disease Indication, 2015–2022
- 2.3 Global Market by End-User
- 2.3.1 Global Market Value & Volume Comparison by End-User (2015-2031)
- 2.3.2 Global Market Value & Volume Market Share by End-User in 2021
- 2.3.3 Global Market Attractiveness Analysis by End-User, 2015–2022
- 2.4 Global Market Outlook by Region
- 2.4.1 Global Market Value & Volume Comparison by Region (2015-2031)
- 2.4.2 Global Market Value & Volume Market Share by Region in 2021
- 2.4.3 Global Market Attractiveness Analysis by Region, 2015–2022
- 2.5 Global Market Outlook (2015-2031)
- 2.5.1 Global Market Value & Volume (2015–2022)
- 2.5.2 Global Market Value & Volume (2023-2031)
- 2.6 Global Market Value & Volume by Regions
- 2.6.1 Global Market Value & Volume Comparison by Region (2015–2022)
- 2.6.2 Global Market Value & Volume Comparison by Region (2023-2031)
- 2.7 Global Market Value & Volume by Product Type
- 2.7.1 Global Market Value & Volume Comparison by Product Type (2015–2022)
- 2.7.2 Global Market Value & Volume Comparison by Product Type (2023-2031)
- 2.8 Global Market Value & Volume by Disease Indication
- 2.8.1 Global Market Value & Volume Comparison by Disease Indication (2015–2022)
- 2.8.2 Global Market Value & Volume Comparison by Disease Indication (2023-2031)
- 2.9 Global Market Value & Volume by End-User
- 2.9.1 Global Market Value & Volume Comparison by End-User (2015–2022)
- 2.9.2 Global Market Value & Volume Comparison by End-User (2023-2031)
- 2.10 Global Market Y-o-Y Growth Rate Comparison 2016–2031
- 2.10.1 Global Market Y-o-Y Growth Rate by Region
- 2.10.2 Global Market Y-o-Y Growth Rate by Product Type
- 2.10.3 Global Market Y-o-Y Growth Rate by Disease Indication
- 2.10.4 Global Market Y-o-Y Growth Rate by End-User
- 2.11 Global Market Share Comparison 2015–2030
- 2.11.1 Global Market Share by Region
- 2.11.2 Global Market Share by Product Type
- 2.11.3 Global Market Share by Disease Indication
- 2.11.4 Global Market Share by End-User
- 2.1 Global Market Value & Volume Comparison by Product Type (2015-2031)
- Chapter 3 North America Cancer Imaging System Market Overview
- 3.1 North America Market by Product Type
- 3.1.1 North America Market Value & Volume Comparison by Product Type (2015-2031)
- 3.1.2 North America Market Value & Volume Market Share by Product Type in 2021
- 3.2 North America Market Value & Volume Comparison by Disease Indication (2015-2031)
- 3.2.1 North America Market Value & Volume Market Share by Disease Indication in 2021
- 3.2.2 North America Market Attractiveness Analysis by Disease Indication, 2015–2022
- 3.3 North America Market by End-User
- 3.3.1 North America Market Value & Volume Comparison by End-User (2015-2031)
- 3.3.2 North America Market Value & Volume Market Share by End-User in 2021
- 3.3.3 North America Market Attractiveness Analysis by End-User, 2015–2022
- 3.4 North America Market Outlook by Region
- 3.4.1 North America Market Value & Volume Comparison by Region (2015-2031)
- 3.4.2 North America Market Value & Volume Market Share by Region in 2021
- 3.4.3 North America Market Attractiveness Analysis by Region, 2015–2022
- 3.5 North America Market Outlook (2015-2031)
- 3.5.1 North America Market Value & Volume (2015–2022)
- 3.5.2 North America Market Value & Volume (2023-2031)
- 3.6 North America Market Value & Volume by Regions
- 3.6.1 North America Market Value & Volume Comparison by Region (2015–2022)
- 3.6.2 North America Market Value & Volume Comparison by Region (2023-2031)
- 3.7 North America Market Value & Volume by Product Type
- 3.7.1 North America Market Value & Volume Comparison by Product Type (2015–2022)
- 3.7.2 North America Market Value & Volume Comparison by Product Type (2023-2031)
- 3.8 North America Market Value & Volume by Disease Indication
- 3.8.1 North America Market Value & Volume Comparison by Disease Indication (2015–2022)
- 3.8.2 North America Market Value & Volume Comparison by Disease Indication (2023-2031)
- 3.9 North America Market Value & Volume by End-User
- 3.9.1 North America Market Value & Volume Comparison by End-User (2015–2022)
- 3.9.2 North America Market Value & Volume Comparison by End-User (2023-2031)
- 3.10 North America Market Y-o-Y Growth Rate Comparison 2016–2031
- 3.10.1 North America Market Y-o-Y Growth Rate by Region
- 3.10.2 North America Market Y-o-Y Growth Rate by Product Type
- 3.10.3 North America Market Y-o-Y Growth Rate by Disease Indication
- 3.10.4 North America Market Y-o-Y Growth Rate by End-User
- 3.11 North America Market Share Comparison 2015–2030
- 2.11.1 North America Market Share by Region
- 3.11.2 North America Market Share by Product Type
- 3.11.3 North America Market Share by Disease Indication
- 3.11.4 North America Market Share by End-User
- 3.1 North America Market by Product Type
- Chapter 4 Europe Cancer Imaging System Market Overview
- 4.1 Europe Market by Product Type
- 4.1.1 Europe Market Value & Volume Comparison by Product Type (2015-2031)
- 4.1.2 Europe Market Value & Volume Market Share by Product Type in 2021
- 4.2 Europe Market Value & Volume Comparison by Disease Indication (2015-2031)
- 4.2.1 Europe Market Value & Volume Market Share by Disease Indication in 2021
- 4.2.2 Europe Market Attractiveness Analysis by Disease Indication, 2015–2022
- 4.3 Europe Market by End-User
- 4.3.1 Europe Market Value & Volume Comparison by End-User (2015-2031)
- 4.3.2 Europe Market Value & Volume Market Share by End-User in 2021
- 4.3.3 Europe Market Attractiveness Analysis by End-User, 2015–2022
- 4.4 Europe Market Outlook by Region
- 4.4.1 Europe Market Value & Volume Comparison by Region (2015-2031)
- 4.4.2 Europe Market Value & Volume Market Share by Region in 2021
- 4.4.3 Europe Market Attractiveness Analysis by Region, 2015–2022
- 4.5 Europe Market Outlook (2015-2031)
- 4.5.1 Europe Market Value & Volume (2015–2022)
- 4.5.2 Europe Market Value & Volume (2023-2031)
- 4.6 Europe Market Value & Volume by Regions
- 4.6.1 Europe Market Value & Volume Comparison by Region (2015–2022)
- 4.6.2 Europe Market Value & Volume Comparison by Region (2023-2031)
- 4.7 Europe Market Value & Volume by Product Type
- 4.7.1 Europe Market Value & Volume Comparison by Product Type (2015–2022)
- 4.7.2 Europe Market Value & Volume Comparison by Product Type (2023-2031)
- 4.8 Europe Market Value & Volume by Disease Indication
- 4.8.1 Europe Market Value & Volume Comparison by Disease Indication (2015–2022)
- 4.8.2 Europe Market Value & Volume Comparison by Disease Indication (2023-2031)
- 4.9 Europe Market Value & Volume by End-User
- 4.9.1 Europe Market Value & Volume Comparison by End-User (2015–2022)
- 4.9.2 Europe Market Value & Volume Comparison by End-User (2023-2031)
- 4.9 Europe Market Y-o-Y Growth Rate Comparison 2016–2031
- 4.10.1 Europe Market Y-o-Y Growth Rate by Region
- 4.10.2 Europe Market Y-o-Y Growth Rate by Product Type
- 4.10.3 Europe Market Y-o-Y Growth Rate by Disease Indication
- 4.10.4 Europe Market Y-o-Y Growth Rate by End-User
- 4.11 Europe Market Share Comparison 2015–2030
- 4.11.1 Europe Market Share by Region
- 4.11.2 Europe Market Share by Product Type
- 4.11.3 Europe Market Share by Disease Indication
- 4.11.4 Europe Market Share by End-User
- 4.1 Europe Market by Product Type
- Chapter 5 Asia-Pacific Cancer Imaging System Market Overview
- 5.1 Asia-Pacific Market by Product Type
- 5.1.1 Asia-Pacific Market Value & Volume Comparison by Product Type (2015-2031)
- 5.1.2 Asia-Pacific Market Value & Volume Market Share by Product Type in 2021
- 5.2 Asia-Pacific Market Value & Volume Comparison by Disease Indication (2015-2031)
- 5.2.1 Asia-Pacific Market Value & Volume Market Share by Disease Indication in 2021
- 5.2.2 Asia-Pacific Market Attractiveness Analysis by Disease Indication, 2015–2022
- 5.3 Asia-Pacific Market by End-User
- 5.3.1 Asia-Pacific Market Value & Volume Comparison by End-User (2015-2031)
- 5.3.2 Asia-Pacific Market Value & Volume Market Share by End-User in 2021
- 5.3.3 Asia-Pacific Market Attractiveness Analysis by End-User, 2015–2022
- 5.4 Asia-Pacific Market Outlook by Region
- 5.4.1 Asia-Pacific Market Value & Volume Comparison by Region (2015-2031)
- 5.4.2 Asia-Pacific Market Value & Volume Market Share by Region in 2021
- 5.4.3 Asia-Pacific Market Attractiveness Analysis by Region, 2015–2022
- 5.5 Asia-Pacific Market Outlook (2015-2031)
- 5.5.1 Asia-Pacific Market Value & Volume (2015–2022)
- 5.5.2 Asia-Pacific Market Value & Volume (2023-2031)
- 5.6 Asia-Pacific Market Value & Volume by Regions
- 5.6.1 Asia-Pacific Market Value & Volume Comparison by Region (2015–2022)
- 5.6.2 Asia-Pacific Market Value & Volume Comparison by Region (2023-2031)
- 5.7 Asia-Pacific Market Value & Volume by Product Type
- 5.7.1 Asia-Pacific Market Value & Volume Comparison by Product Type (2015–2022)
- 5.7.2 Asia-Pacific Market Value & Volume Comparison by Product Type (2023-2031)
- 5.8 Asia-Pacific Market Value & Volume by Disease Indication
- 5.8.1 Asia-Pacific Market Value & Volume Comparison by Disease Indication (2015–2022)
- 5.8.2 Asia-Pacific Market Value & Volume Comparison by Disease Indication (2023-2031)
- 5.9 Asia-Pacific Market Value & Volume by End-User
- 5.9.1 Asia-Pacific Market Value & Volume Comparison by End-User (2015–2022)
- 5.9.2 Asia-Pacific Market Value & Volume Comparison by End-User (2023-2031)
- 5.10 Asia-Pacific Market Y-o-Y Growth Rate Comparison 2016–2031
- 5.10.1 Asia-Pacific Market Y-o-Y Growth Rate by Region
- 5.10.2 Asia-Pacific Market Y-o-Y Growth Rate by Product Type
- 5.10.3 Asia-Pacific Market Y-o-Y Growth Rate by Disease Indication
- 5.10.4 Asia-Pacific Market Y-o-Y Growth Rate by End-User
- 5.11 Asia-Pacific Market Share Comparison 2015–2030
- 5.11.1 Asia-Pacific Market Share by Region
- 5.11.2 Asia-Pacific Market Share by Product Type
- 5.11.3 Asia-Pacific Market Share by Disease Indication
- 5.11.4 Asia-Pacific Market Share by End-User
- 5.1 Asia-Pacific Market by Product Type
- Chapter 6 Latin America Cancer Imaging System Market Overview
- 6.1 Latin America Market by Product Type
- 6.1.1 Latin America Market Value & Volume Comparison by Product Type (2015-2031)
- 6.1.2 Latin America Market Value & Volume Market Share by Product Type in 2021
- 6.2 Latin America Market Value & Volume Comparison by Disease Indication (2015-2031)
- 6.2.1 Latin America Market Value & Volume Market Share by Disease Indication in 2021
- 6.2.2 Latin America Market Attractiveness Analysis by Disease Indication, 2015–2022
- 6.3 Latin America Market by End-User
- 6.3.1 Latin America Market Value & Volume Comparison by End-User (2015-2031)
- 6.3.2 Latin America Market Value & Volume Market Share by End-User in 2021
- 6.3.3 Latin America Market Attractiveness Analysis by End-User, 2015–2022
- 6.4 Latin America Market Outlook by Region
- 6.4.1 Latin America Market Value & Volume Comparison by Region (2015-2031)
- 6.4.2 Latin America Market Value & Volume Market Share by Region in 2021
- 6.4.3 Latin America Market Attractiveness Analysis by Region, 2015–2022
- 6.5 Latin America Market Outlook (2015-2031)
- 6.5.1 Latin America Market Value & Volume (2015–2022)
- 6.5.2 Latin America Market Value & Volume (2023-2031)
- 6.6 Latin America Market Value & Volume by Regions
- 6.6.1 Latin America Market Value & Volume Comparison by Region (2015–2022)
- 6.6.2 Latin America Market Value & Volume Comparison by Region (2023-2031)
- 6.7 Latin America Market Value & Volume by Product Type
- 6.7.1 Latin America Market Value & Volume Comparison by Product Type (2015–2022)
- 6.7.2 Latin America Market Value & Volume Comparison by Product Type (2023-2031)
- 6.8 Latin America Market Value & Volume by Disease Indication
- 6.8.1 Latin America Market Value & Volume Comparison by Disease Indication (2015–2022)
- 6.8.2 Latin America Market Value & Volume Comparison by Disease Indication (2023-2031)
- 6.9 Latin America Market Value & Volume by End-User
- 6.9.1 Latin America Market Value & Volume Comparison by End-User (2015–2022)
- 6.9.2 Latin America Market Value & Volume Comparison by End-User (2023-2031)
- 6.10 Latin America Market Y-o-Y Growth Rate Comparison 2016–2031
- 6.10.1 Latin America Market Y-o-Y Growth Rate by Region
- 6.10.2 Latin America Market Y-o-Y Growth Rate by Product Type
- 6.10.3 Latin America Market Y-o-Y Growth Rate by Disease Indication
- 6.10.4 Latin America Market Y-o-Y Growth Rate by End-User
- 6.11 Latin America Market Share Comparison 2015–2030
- 6.11.1 Latin America Market Share by Region
- 6.11.2 Latin America Market Share by Product Type
- 6.11.3 Latin America Market Share by Disease Indication
- 6.11.4 Latin America Market Share by End-User
- 6.1 Latin America Market by Product Type
- Chapter 7 MEA Cancer Imaging System Market Overview
- 7.1 MEA Market by Product Type
- 7.1.1 MEA Market Value & Volume Comparison by Product Type (2015-2031)
- 7.1.2 MEA Market Value & Volume Market Share by Product Type in 2021
- 7.2 MEA Market Value & Volume Comparison by Disease Indication (2015-2031)
- 7.2.1 MEA Market Value & Volume Market Share by Disease Indication in 2021
- 7.2.2 MEA Market Attractiveness Analysis by Disease Indication, 2015–2022
- 7.3 MEA Market by End-User
- 7.3.1 MEA Market Value & Volume Comparison by End-User (2015-2031)
- 7.3.2 MEA Market Value & Volume Market Share by End-User in 2021
- 7.3.3 MEA Market Attractiveness Analysis by End-User, 2015–2022
- 7.4 MEA Market Outlook by Region
- 7.4.1 MEA Market Value & Volume Comparison by Region (2015-2031)
- 7.4.2 MEA Market Value & Volume Market Share by Region in 2021
- 7.4.3 MEA Market Attractiveness Analysis by Region, 2015–2022
- 7.5 MEA Market Outlook (2015-2031)
- 7.5.1 MEA Market Value & Volume (2015–2022)
- 7.5.2 MEA Market Value & Volume (2023-2031)
- 7.6 MEA Market Value & Volume by Regions
- 7.6.1 MEA Market Value & Volume Comparison by Region (2015–2022)
- 7.6.2 MEA Market Value & Volume Comparison by Region (2023-2031)
- 7.7 MEA Market Value & Volume by Product Type
- 7.7.1 MEA Market Value & Volume Comparison by Product Type (2015–2022)
- 7.7.2 MEA Market Value & Volume Comparison by Product Type (2023-2031)
- 7.8 MEA Market Value & Volume by Disease Indication
- 7.8.1 MEA Market Value & Volume Comparison by Disease Indication (2015–2022)
- 7.8.2 MEA Market Value & Volume Comparison by Disease Indication (2023-2031)
- 7.9 MEA Market Value & Volume by End-User
- 7.9.1 MEA Market Value & Volume Comparison by End-User (2015–2022)
- 7.9.2 MEA Market Value & Volume Comparison by End-User (2023-2031)
- 7.10 MEA Market Y-o-Y Growth Rate Comparison 2016–2031
- 7.10.1 MEA Market Y-o-Y Growth Rate by Region
- 7.10.2 MEA Market Y-o-Y Growth Rate by Product Type
- 7.10.3 MEA Market Y-o-Y Growth Rate by Disease Indication
- 7.10.4 MEA Market Y-o-Y Growth Rate by End-User
- 7.11 MEA Market Share Comparison 2015–2030
- 7.11.1 MEA Market Share by Region
- 7.11.2 MEA Market Share by Product Type
- 7.11.3 MEA Market Share by Disease Indication
- 7.11.4 MEA Market Share by End-User
- 7.1 MEA Market by Product Type
- Chapter 8 Global Cancer Imaging System Market Company Profiles
- 8.1 Market Competition Scenario Analysis, By Company
- 8.2 Competitor Landscape
- 8.3 Company Share Analysis
- 8.4 Company Profiles
- 8.4.1 GE Healthcare
- 8.4.1.1 Company Overview
- 8.4.1.2 Business Description
- 8.4.1.3 Product Portfolio
- 8.4.1.4 Key Financials
- 8.4.1.5 Key Developments
- 8.4.1.6 SWOT Analysis
- 8.4.2 Hitachi Medical
- 8.4.2.1 Company Overview
- 8.4.2.2 Business Description
- 8.4.2.3 Product Portfolio
- 8.4.2.4 Key Financials
- 8.4.2.5 Key Developments
- 8.4.2.6 SWOT Analysis
- 8.4.3 Becton, Dickinson and Company
- 8.4.3.1 Company Overview
- 8.4.3.2 Business Description
- 8.4.3.3 Product Portfolio
- 8.4.3.4 Key Financials
- 8.4.3.5 Key Developments
- 8.4.3.6 SWOT Analysis
- 8.4.4 Toshiba Medical Corporation
- 8.4.4.1 Company Overview
- 8.4.4.2 Business Description
- 8.4.4.3 Product Portfolio
- 8.4.4.4 Key Financials
- 8.4.4.5 Key Developments
- 8.4.4.6 SWOT Analysis
- 8.4.5 Konica Minolta
- 8.4.5.1 Company Overview
- 8.4.5.2 Business Description
- 8.4.5.3 Product Portfolio
- 8.4.5.4 Key Financials
- 8.4.5.5 Key Developments
- 8.4.5.6 SWOT Analysis
- 8.4.6 Neusoft Medical
- 8.4.6.1 Company Overview
- 8.4.6.2 Business Description
- 8.4.6.3 Product Portfolio
- 8.4.6.4 Key Financials
- 8.4.6.5 Key Developments
- 8.4.6.6 SWOT Analysis
- 8.4.7 Thermo Fisher Scientific Inc
- 8.4.7.1 Company Overview
- 8.4.7.2 Business Description
- 8.4.7.3 Product Portfolio
- 8.4.7.4 Key Financials
- 8.4.7.5 Key Developments
- 8.4.7.6 SWOT Analysis
- 8.4.8 Esaote
- 8.4.8.1 Company Overview
- 8.4.8.2 Business Description
- 8.4.8.3 Product Portfolio
- 8.4.8.4 Key Financials
- 8.4.8.5 Key Developments
- 8.4.8.6 SWOT Analysis
- 8.4.9 Dilon Diagnostics
- 8.4.9.1 Company Overview
- 8.4.9.2 Business Description
- 8.4.9.3 Product Portfolio
- 8.4.9.4 Key Financials
- 8.4.9.5 Key Developments
- 8.4.9.6 SWOT Analysis
- 8.4.10 Fujifilm Holdings
- 8.4.10.1 Company Overview
- 8.4.10.2 Business Description
- 8.4.10.3 Product Portfolio
- 8.4.10.4 Key Financials
- 8.4.10.5 Key Developments
- 8.4.10.6 SWOT Analysis
- 8.4.11 Other Key Players
- 8.4.1 GE Healthcare
- Chapter 9 Research Methodology
- 9.1 Research Methodology
- 9.2 Primary Research
- 9.3 Secondary Research
- 9.4 Report Scope
- Chapter 10 About Us
- 10.1 Who we are:
- Chapter 11 Disclaimer
- Chapter 1 Global Cancer Imaging System Market Outlook
-
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!